IE55025B1 - Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production - Google Patents

Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production

Info

Publication number
IE55025B1
IE55025B1 IE1329/83A IE132983A IE55025B1 IE 55025 B1 IE55025 B1 IE 55025B1 IE 1329/83 A IE1329/83 A IE 1329/83A IE 132983 A IE132983 A IE 132983A IE 55025 B1 IE55025 B1 IE 55025B1
Authority
IE
Ireland
Prior art keywords
teichomycin
paraffin
factor
column
absorption spectrum
Prior art date
Application number
IE1329/83A
Other languages
English (en)
Other versions
IE831329L (en
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IE831329L publication Critical patent/IE831329L/xx
Publication of IE55025B1 publication Critical patent/IE55025B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE1329/83A 1982-06-08 1983-06-07 Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production IE55025B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (2)

Publication Number Publication Date
IE831329L IE831329L (en) 1983-12-08
IE55025B1 true IE55025B1 (en) 1990-04-25

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1329/83A IE55025B1 (en) 1982-06-08 1983-06-07 Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production

Country Status (32)

Country Link
US (1) US4542018A (el)
JP (5) JPS591423A (el)
KR (1) KR900008246B1 (el)
AU (1) AU560966B2 (el)
BE (1) BE896993A (el)
BG (1) BG60529B2 (el)
CA (1) CA1208204A (el)
CH (1) CH657139A5 (el)
DE (1) DE3320342A1 (el)
DK (1) DK159117C (el)
ES (2) ES8503689A1 (el)
FI (1) FI73697C (el)
FR (1) FR2528050B1 (el)
GB (1) GB2121401B (el)
GR (1) GR78267B (el)
HK (1) HK55887A (el)
HU (1) HU193538B (el)
IE (1) IE55025B1 (el)
IL (1) IL68819A0 (el)
IT (1) IT1212085B (el)
LU (1) LU84853A1 (el)
MY (1) MY8700002A (el)
NL (1) NL8301980A (el)
NO (1) NO159104C (el)
NZ (1) NZ204480A (el)
PH (1) PH19533A (el)
PT (1) PT76831B (el)
SE (1) SE459094B (el)
SG (1) SG70686G (el)
SU (1) SU1318170A3 (el)
UA (1) UA6025A1 (el)
ZA (1) ZA833607B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
EP0560795B1 (en) * 1990-12-05 1996-02-21 GRUPPO LEPETIT S.p.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US6218505B1 (en) 1996-04-23 2001-04-17 Biosearch Italia S.P.A. Chemical process for preparing amide derivatives of antibiotic A 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20050130909A1 (en) * 2002-11-18 2005-06-16 Luigi Colombo Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IT1212085B (it) 1989-11-08
NZ204480A (en) 1986-04-11
BG60529B2 (bg) 1995-07-28
GB8315003D0 (en) 1983-07-06
FI73697B (fi) 1987-07-31
IE831329L (en) 1983-12-08
PT76831A (en) 1983-07-01
BE896993A (fr) 1983-12-07
DK245883A (da) 1983-12-09
DE3320342A1 (de) 1983-12-08
NO159104B (no) 1988-08-22
ZA833607B (en) 1984-03-28
CA1208204A (en) 1986-07-22
SE8303211D0 (sv) 1983-06-07
FR2528050B1 (fr) 1987-03-20
JPH02291279A (ja) 1990-12-03
AU1496883A (en) 1983-12-15
JPH0224278B2 (el) 1990-05-29
NO159104C (no) 1988-11-30
HU193538B (en) 1987-10-28
DK159117C (da) 1991-02-11
SE459094B (sv) 1989-06-05
JPH0415237B2 (el) 1992-03-17
IL68819A0 (en) 1983-09-30
KR900008246B1 (ko) 1990-11-06
PT76831B (en) 1986-04-09
JPH0517237B2 (el) 1993-03-08
DK245883D0 (da) 1983-05-31
JPS591423A (ja) 1984-01-06
ES536770A0 (es) 1985-08-16
DE3320342C2 (el) 1991-07-11
GB2121401B (en) 1985-09-18
JPH02291278A (ja) 1990-12-03
FI831660A0 (fi) 1983-05-12
KR840005170A (ko) 1984-11-05
IT8321432A0 (it) 1983-06-02
AU560966B2 (en) 1987-04-30
ES8506748A1 (es) 1985-08-16
NO831754L (no) 1983-12-09
NL8301980A (nl) 1984-01-02
US4542018A (en) 1985-09-17
MY8700002A (en) 1987-12-31
SE8303211L (sv) 1983-12-09
JPH02288887A (ja) 1990-11-28
PH19533A (en) 1986-05-20
FI831660L (fi) 1983-12-09
HK55887A (en) 1987-08-07
SG70686G (en) 1987-07-03
GB2121401A (en) 1983-12-21
ES522941A0 (es) 1985-04-01
FR2528050A1 (fr) 1983-12-09
JPH02288888A (ja) 1990-11-28
ES8503689A1 (es) 1985-04-01
JPH0415238B2 (el) 1992-03-17
LU84853A1 (fr) 1984-03-07
UA6025A1 (uk) 1994-12-29
JPH0517236B2 (el) 1993-03-08
GR78267B (el) 1984-09-26
FI73697C (fi) 1987-11-09
DK159117B (da) 1990-09-03
CH657139A5 (fr) 1986-08-15
SU1318170A3 (ru) 1987-06-15

Similar Documents

Publication Publication Date Title
US4542018A (en) Teichomycin A2 pure single factors 1, 2, 3, 4 and 5 and method for their production
US4322343A (en) Pseudo-aglycone of actaplanin
US4699977A (en) Antibiotic L 17046 and process for preparing it
CA1250093A (en) Chemical process for preparing antibiotic l 17392 (deglucoteicoplanin) and its salts
US3801464A (en) Antibiotic a16886 and process for production thereof
US3183154A (en) Antibiotic pactacin and method of production
JPH07114704B2 (ja) 抗生物質ａ４２８６７およびその付加塩
US2832788A (en) Crystalline alkaline earth metal salts of 4-amino-3-isoxazolidone
EP0124343A1 (en) Actaplanin antibiotics
US4264736A (en) Antibiotic 890A10
US5041534A (en) Process for preparing antibiotic L 17054
JPH03197489A (ja) 抗生物質ｔａｎ―１１７１およびその製造法

Legal Events

Date Code Title Description
MK9A Patent expired